There was both good news and bad news for Apple yesterday, reports the UK’s The Telegraph: The U.S. Securities & Exchange Commission (SEC) is said to be reviewing the timing of disclosures over the health of Apple chief executive Steve Jobs as the company unveiled a jump in sales over Christmas. Jobs, who suffered from pancreatic cancer in 2004, last week announced he was to take a five-month leave of absence as his medical condition was more serious than first thought. The announcement came just a week after telling the markets he was suffering from an easily treatable hormone imbalance. The SEC is now understood to be looking into not only the timing of those statements–what Jobs knew and when, and at what point the company’s board knew of his poor health. The review by the SEC is a cautionary one, and does not necessarily indicate that the regulator has detected wrongdoing. The company announced a stellar set of first-quarter results, with sales of $10.2 billion in the three months to December–beating estimates of $9.74 billion–and earnings per share of $1.78, beating estimates of $1.40. Shares in the company rose during extended trading as it reported strong sales in both iPods and Mac computers…

Click here for the full story

About the Author:

eSchool News